Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies

Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies

(2014) Corrado Barbui et al.   DRUG SAFETY

Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database

(2013) Giuseppe Roberto et al.   CEPHALALGIA

Comparative efficacy of triptans for the abortive treatment of migraine: A multiple treatment comparison meta-analysis

(2013) Kristian Thorlund et al.   CEPHALALGIA

Medication-overuse headache

(2013) Zaza Katsarava et al.   CURRENT OPINION IN NEUROLOGY

Italian guidelines for primary headaches: 2012 revised version

(2012) Paola Sarchielli et al.   JOURNAL OF HEADACHE AND PAIN

Basilar artery occlusion in migraine-like headache: a possible triggering effect of sumatriptan

(2011) Sibel Gazioglu et al.   NEUROLOGICAL SCIENCES

Use of Serotonergic Drugs and the Risk of Bleeding

(2010) B M Verdel et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Triptan Therapy in Migraine

(2010) Elizabeth Loder   NEW ENGLAND JOURNAL OF MEDICINE

From Randomized Controlled Trials to Observational Studies

(2009) Stuart L. Silverman   AMERICAN JOURNAL OF MEDICINE

Diseases and Drugs That Increase Risk of Acute Large Bowel Ischemia

(2009) George F. Longstreth et al.   Clinical Gastroenterology and Hepatology

Triptan Use as a Function of Cardiovascular Risk. A Population-Based Study

(2009) Marcelo E. Bigal et al.   HEADACHE

History of the Use of Ergotamine and Dihydroergotamine in Migraine From 1906 and Onward

(2008) PC Tfelt-Hansen et al.   CEPHALALGIA